Anagrelide Hydrochloride

Anagrelide Hydrochloride API (CAS No: 58579-51-4) is precisely produced at Amber Lifesciences Pvt. Ltd. in GMP-compliant and ISO 9001:2015 certified facilities, ensuring outstanding purity, consistency, and adherence to global regulatory standards. Every batch is delivered with a detailed Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), aligned with USP/EP pharmacopeial guidelines.

Anagrelide Hydrochloride is a platelet-reducing agent primarily used in the treatment of essential thrombocythemia to lower elevated platelet counts and reduce the risk of thrombotic complications. It works by inhibiting the maturation of megakaryocytes into platelets. Our API undergoes rigorous quality control procedures and validated production processes to guarantee reliable performance in pharmaceutical formulations.

Amber Lifesciences supports pharmaceutical manufacturers, exporters, contract developers, and formulation partners across Asia, Europe, the Middle East, and LATAM regions by offering dependable supply chains, technical support, and complete regulatory documentation to facilitate smooth product registration and fast market entry.

Storage & Transportation

Classified as non-Dangerous Goods. Store at controlled room temperature (20°C to 25°C / 68°F to 77°F), protected from moisture, light, and excessive heat. Handle following standard pharmaceutical transport and storage protocols.